Communiqués Wockhardt Limited

Actions

WOCKPHARMA

INE049B01025

Produits pharmaceutiques

Temps Différé NSE India S.E. 12:28:30 30/09/2026			Varia. 5j.	Varia. 1 janv.
2 116,30 ^INR	-3,55%		-9,16%	+46,34%

10/08	Wockhardt Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI
01/06	Wockhardt reçoit l'approbation de la FDA américaine pour le Zaynich (céfépime et zidebactam) dans le traitement des infections urinaires compliquées, y compris la pyélonéphrite	CI

Communiqués

20/08/22	Wockhardt : Corp Restructuring - others	PU
04/04/22	Wockhardt : Appointment	PU
21/03/22	Wockhardt Limited - Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom	AQ
16/03/22	National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt's novel once-a-day MDR Gram-negative antibiotic WCK 6777	AQ
16/03/22	Wockhardt : Press Release	PU
13/03/22	Wockhardt : Newspaper Advertisements	PU
03/03/22	Wockhardt : Outcome of Board Meeting	PU
28/01/22	Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd Quarter Results for Financial Year 2021-22, today	AQ
11/02/21	Wockhardt : UK Government Announces COVID-19 Vaccination Contract Extension with Wockhardt	AQ
01/02/21	Wockhardt : profitability for Q3FY21 at Rs.15 crore	AQ
30/01/21	Wockhardt : Man arrested over package sent to vaccine plant in Wales	AQ
27/01/21	Wockhardt : UK vaccine plant evacuated after getting suspicious package	AQ
02/12/20	Wockhardt : hosts visit of Prime Minister of United Kingdom	AQ
21/04/20	Wockhardt : receives US FDA Qualified Infectious Disease Product designation for WCK 6777, a first ever once-a-day -lactam enhancer class antibiotic	AQ
28/01/20	Wockhardt : Q3FY20 sales at Rs. 869 crore, EBITDA at Rs.109 crore, PAT at Rs 9 crore compared to loss of in PY	AQ
29/06/15	Wockhardt : receives ANDA approval for pain medication Oxycodone liquid	PU
12/08/14	Wockhardt : FINANCIAL RESULTS FY 2014-15 Q1 (APR-JUN 2014)	PU
26/05/14	WOCKHARDT : ANNUAL FINANCIAL RESULTS (FY 13-14)	PU
14/08/13	Wockhardt Limited : FINANCIAL RESULTS FY 2013-14 Q1 (APR-JUN 2013)	PU
27/05/13	Wockhardt Limited : Wockhardt Annual Financial Results (FY12-13)	PU
15/02/13	Wockhardt Limited : FINANCIAL RESULTS FY 2012 – 13 Q3 (OCT – DEC 2012)	PU
11/01/13	Wockhardt Limited : Wockhardt receives the 'Best Enterprise' award from the Europe Business Assembly	PU
08/01/13	Wockhardt Limited : Wockhardt launches generic version of anti-convulsant drug Lamictal XR	PU
14/11/12	Wockhardt Limited : FINANCIAL RESULTS FY 2012-13 Q2 (JUL- SEP 2012)	PU
28/08/12	Wockhardt Limited : Wockhardt receives US FDA approval for generic version of Parkinsonism drug Requip XL®	PU